Starting with the Right Stuff: The Challenge for Molecular Diagnostic Assays
Dr. Carolyn Compton, National Cancer Institute, speaking at Molecular Diagnostics World Congress 2011.
miRNA Replacement Therapy in Cancer through Polyplex-Mediated miRNA Delivery In Vivo
Professor Achim Aigner, Institute of Pharmacology / bpc, Philipps-University Marburg, speaking at RNAi Europe 2011.
Causes and Consequences of microRNA Dysregulation in Cancer
Dr Carlo Croce, The Ohio State University, speaking at RNAi Europe 2011.
Role of Histone Methylation in Mammalian Genomic Imprinting
Robert Feil, CNRS Institute of Molecular Genetics, speaking at Epigenetics 2011.
A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics
Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.
High Content Screening for Cytoskeletal Rearrangements
María Montoya, Centro Nacional de Investigaciones Cardiovasculares, speaking at Screening Europe 2011
RNA-Seq for High Throughput Clinical Studies
Wenzhong Xiao, Assistant Professor of Bioinformatics, Massachusetts General Hospital, speaking at Next-Gen Sequencing Congress 2011.
The Epigenetic Regulation of microRNA Genes and Their Role in Cell Invasion and Motility in Human Melanomas
Ranjan Perera, Associate Professor, Sandford Burnham Medical Research Institute, Speaking at Epigenetics World Congress 2011
Capturing Ephemeral Hemimethylation at CpG and non-CpG Cytosines: Insights From Molecules and Math
Diane Genereux, Post Doctoral Associate, Department of Biology, University of Washington, speaking at Epigenetics World Congress 2011.